Oct
20
Constellation Pharmaceuticals To Present at First Annual Boston Biotech R&D Conference
Posted in Constellation in the News, NewsroomCAMBRIDGE, MA – October 20, 2008 – Constellation Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel drugs targeting selective regulators of epigenetic function, today will present at the 2008 Boston Biotech R&D Conference, at 3:40 PM, October 22, 2008 at Harvard Medical School in Boston, Mass. Robert Tepper, M.D., Constellation Chief Scientific [...]